Search


RBC Global Healthcare Conference: Senior Biotech Analyst Luca Issi shares his thoughts on the current state of gene and cell therapy
He shares his overall thoughts on the biotech market, and discusses gene therapies, RNA editing, and cell therapy. Luca Issi RBC 2025
May 21


RBC analyst Luca Issi joins BiotechTV for Analyst Thursdays from Boston
Luca Issi gives his take on the sector and discusses news regarding Moderna, Caribou, Ultragenyx, Biomarin, Alnylam, Lexeo, and Wave Life...
Jun 20, 2024